This study is evaluating changes in P2X7R levels and their association with changes in NLRP3 inflammasome levels in patients with newly diagnosed PD or AD receiving routine treatment in comparison with an age- and gender-matched group [176]. Here, NLRP3 is linked to Parkinson disease.